Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Paranasal Sinus Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Cisplatin 12Radiotherapy 10Cetuximab 9Fluorouracil 6Drug Therapy 5Docetaxel 5pembrolizumab 3Radiotherapy, Intensity-Modulated 3Radiation 3Laser Therapy 3Hydroxyurea 3sargramostim 2Surveys and Questionnaires 2Resistance Training 2Psychiatric Rehabilitation 2Nutritional Status 2Nicotine 2Counseling 2Celecoxib 2Carboplatin 2Bupropion 2Bronchoscopy 2sodium thiosulfate 1motexafin gadolinium 1gossypol acetic acid 1durvalumab 1adavosertib 1Zinc Oxide 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Laryngeal Neoplasms × Chemoprevention × Clear all
NCT01469429 2020-02-20

Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.

Ohio State University Comprehensive Cancer Center

Phase 1/2 Completed
70 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡